Biologics APIs

Apr 03, 2018
By Pharmaceutical Technology Editors
The agency has accepted AstraZeneca’s biologics license application for an investigational leukemia drug candidate and granted it priority review.
Apr 02, 2018
Pharmaceutical Technology
Access to multiple analytical techniques is essential for fully characterizing complex protein formulations.
Mar 29, 2018
By Pharmaceutical Technology Editors
EMA has recommended approval of the biosimilar for the same indications as Roche’s Herceptin (trastuzumab).
Mar 29, 2018
By Pharmaceutical Technology Editors
Novartis’ Sandoz is seeking approval of its biosimilar referencing Johnson & Johnson’s Remicade (infliximab) for all of Remicade’s indications across gastroenterology, rheumatology, and dermatology.
Mar 29, 2018
By Pharmaceutical Technology Editors
The companies will co-develop and co-promote a CAR-T cell therapy in the United States.
Mar 27, 2018
By Pharmaceutical Technology Editors
Major countries will be ranked based on the potential for biopharma market growth, innovation, and competitiveness.
Mar 26, 2018
By Pharmaceutical Technology Editors
The agreement gives IncoCell Tianjin, a wholly-owned subsidiary of China-based Boyalife Group, access to Cesca’s celluar processing contract development and manufacturing services.
Mar 26, 2018
By Pharmaceutical Technology Editors
Hitachi will manufacture regenerative medicines developed by Daiichi Sankyo and SanBio Group.
Mar 23, 2018
By Pharmaceutical Technology Editors
The collaboration between the two companies aims to finish all necessary work needed to file for a first-in-human study by early 2019.
Mar 22, 2018
By Pharmaceutical Technology Editors
The company plans to install 4000-L disposable bioreactors from ABEC at its new commercial manufacturing facility in Wuxi city, China.
native1_300x100
lorem ipsum